国际眼科纵览 ›› 2025, Vol. 49 ›› Issue (3): 224-229.doi: 10. 3760/cma.j.cn115500-20241127-25311

• 综述 • 上一篇    下一篇

糖皮质激素诱发白内障的机制

简裕峰  张景尚  万修华   

  1. 首都医科大学附属北京同仁医院 北京同仁眼科中心 眼科学与视觉科学北京市重点实验室,北京 100730
  • 收稿日期:2024-11-27 出版日期:2025-06-22 发布日期:2025-06-12
  • 通讯作者: 万修华,Email:xiuhuawan@163.com
  • 基金资助:
    国家自然科学基金(82171037,82471055);北京市科技新星交叉联合课题(20240484565)

Mechanism of glucocorticoid-induced cataracts 

Jian Yufeng, Zhang Jingshang, Wan Xiuhua    

  1. Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University; Beijing Key Laboratory of Ophthalmology and Visual Science, Beijing 100730, China

  • Received:2024-11-27 Online:2025-06-22 Published:2025-06-12
  • Supported by:
    National Natural Science Foundation of China (82171037, 82471055); Beijing Science and Technology Star Cross Joint Project (20240484565)

摘要: 糖皮质激素诱发白内障形成机制复杂,其可通过破坏抗氧化能力加强氧化应激导致晶状体变性,还可以上调上皮间质转化导致晶状体纤维化,降低结构蛋白波形蛋白的表达使得晶状体稳定度降低,影响其透明度,并且糖皮质激素影响离子通道转运,诱导Na-K-ATP 酶失活、调控细胞凋亡、细胞分子异常等机制介导糖皮质激素性白内障的发生。采用甲氨蝶呤等药物进行治疗、降低糖皮质激素使用剂量可降低糖皮质激素性白内障的发生。


关键词: 糖皮质激素, 白内障

Abstract: The mechanisms underlying glucocorticoid-induced cataract formation are complex. Glucocorticoids can exacerbate oxidative stress by impairing antioxidant capacity, leading to lens degeneration. Additionally, they upregulate epithelial-mesenchymal transition (EMT), contributing to lens fibrosis, while reducing the expression of the structural protein vimentin, thereby diminishing lens stability and transparency. Glucocorticoids also mediate cataract development through mechanisms such as disrupting ion channel transport, inactivating Na-K-ATPase, regulating apoptosis, and inducing abnormalities in cellular molecules. Therapeutic interventions, including the use of drugs like methotrexate, and reducing glucocorticoid dosage may help lower the incidence of glucocorticoid-induced cataracts.


Key words: Glucocorticosteroid, Cataract